Amitiza FDA Approval History
FDA Approved: Yes (First approved January 31, 2006)
Brand name: Amitiza
Generic name: lubiprostone
Dosage form: Capsules
Company: Sucampo Pharmaceuticals, Inc.
Treatment for: Constipation, Chronic, Irritable Bowel Syndrome
Amitiza (lubiprostone) is a selective chloride channel activator for the treatment of chronic idiopathic constipation and opioid-induced constipation in adults, and irritable bowel syndrome with constipation in adult women.
Development Timeline for Amitiza
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.